Surgical Site Infections (SSIs) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Surgical Site Infections (SSIs) are a devastating and common complication of hospitalization, occurring in 2% to 5% of patients undergoing surgery in the United States. SSIs lead to increased duration of hospitalization, cost, and risk of death. Each SSI leads to more than one week of additional postoperative hospital days. Most SSIs that do not involve implants are diagnosed within three weeks of surgery. SSIs are classified as either incisional or organ/ space. Incisional SSIs are further classified into superficial or deep. Organ/space SSIs include infections in tissue deep to the fascia that was opened or manipulated during surgery. For all classifications, the infection can occur within 30 days after the operation if no implant was placed or within 90 days if an implant was placed and the infection is related to the incision. SSI will occur because of a complex relationship between microbial characteristics, host characteristics, and wound characteristics. In the USA, ~200,0